Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

3

Usefulness of ΔMELD/month for Prediction of the Mortality in the First Episode of Variceal Bleeding Patients with Liver Cirrhosis: Comparison with CTP, MELD score and ΔCTP/month

Won Ki Bae, M.D., June Sung Lee, M.D., Nam Hoon Kim, M.D., Kyung Ah Kim, M.D., Young Soo Moon, M.D., Min Kyung Oh, Ph.D.

Clin Mol Hepatol. 2007;13(1):51-60. Published online January 1, 1970

View: 2552 Download: 28

Clinical Usefulness of ΔMELD to Predict the Survival of Patients with Liver Cirrhosis

Soo Hoon Eun, M.D., Yun Soo Kim, M.D. Jae Young Jang, M.D., Young Gook Cheon, M.D., Young Seok Kim, M.D., Young Deok Cho, M.D., Joon Sung Lee, M.D., Moon Sung Lee, M.D., Ju Hyun Kim, M.D. Chan Sup Shim, M.D., and Boo Sung Kim, M.D.

Clin Mol Hepatol. 2006;12(4):530-538. Published online January 1, 1970

View: 2740 Download: 20

1

Changes of MELD: Can Exceed Child-Pugh`s Authority?

June Sung Lee

Clin Mol Hepatol. 2006;12(4):475-478. Published online January 1, 1970

View: 2000 Download: 18

1 |

Viewed By 5544	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 4735	MAFLD: How is it different from NAFLD?
Viewed By 4461	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3663	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3631	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 78	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 68	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 57	MAFLD: How is it different from NAFLD?

Search